Latest Insider Transactions at Up Health, Inc. (UPH-WT)
This section provides a real-time view of insider transactions for Up Health, Inc. (UPH-WT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UpHealth, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UpHealth, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.35%
|
$0
$0.35 P/Share
|
|
May 22
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
699
-1.56%
|
$0
$0.48 P/Share
|
|
May 22
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.33%
|
$0
$0.48 P/Share
|
|
May 21
2024
|
Agnes Rey Giraud |
SELL
Open market or private sale
|
Direct |
13,282
-5.83%
|
$0
$0.61 P/Share
|
|
Apr 11
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,658
-7.54%
|
$3,658
$1.04 P/Share
|
|
Apr 11
2024
|
Martin S A Beck Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,340
+20.28%
|
-
|
|
Apr 11
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-1.93%
|
$522
$1.04 P/Share
|
|
Apr 11
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+4.93%
|
-
|
|
Mar 07
2024
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-2.51%
|
$0
$0.7 P/Share
|
|
Mar 07
2024
|
Jay Walter Jennings Acting Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-1.58%
|
$0
$0.7 P/Share
|
|
Jan 31
2024
|
Avi S Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.75%
|
-
|
|
Jan 31
2024
|
Mariya Pylypiv Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+11.16%
|
-
|
|
Jan 31
2024
|
Raluca Dinu Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.75%
|
-
|
|
Jan 31
2024
|
Mark Guinan Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+38.37%
|
-
|
|
Jan 31
2024
|
Luis Machuca Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+38.37%
|
-
|
|
Jan 31
2024
|
Agnes Rey Giraud |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+46.64%
|
-
|
|
Jan 31
2024
|
Chirinjeev Kathuria Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+2.47%
|
-
|
|
Jan 31
2024
|
James S Greene Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Nov 27
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-1.85%
|
$0
$0.61 P/Share
|
|
Nov 21
2023
|
Avi S Katz Director |
SELL
Open market or private sale
|
Direct |
280
-1.98%
|
$0
$0.4 P/Share
|
|
Aug 22
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
701
-1.82%
|
$701
$1.33 P/Share
|
|
Jun 01
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,133
-2.86%
|
$1,133
$1.52 P/Share
|
|
May 22
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-3.6%
|
$1,479
$1.74 P/Share
|
|
Mar 13
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
976
-2.32%
|
$976
$1.76 P/Share
|
|
Feb 03
2023
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
545
-1.28%
|
$1,090
$2.65 P/Share
|
|
Jan 09
2023
|
Samuel Meckey Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
430,000
+50.0%
|
-
|
|
Dec 16
2022
|
Luis Machuca Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,606
+50.0%
|
-
|
|
Dec 16
2022
|
Mark Guinan Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,606
+50.0%
|
-
|
|
Nov 01
2022
|
Ramesh Balakrishnan Pres. & Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,243
-0.23%
|
$0
$0.53 P/Share
|
|
Nov 01
2022
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,468
-1.04%
|
$0
$0.53 P/Share
|
|
Sep 09
2022
|
Chirinjeev Kathuria Director |
SELL
Other acquisition or disposition
|
Direct |
4,688,365
-10.84%
|
-
|
|
Sep 09
2022
|
Mariya Pylypiv Director |
SELL
Other acquisition or disposition
|
Direct |
811,635
-10.75%
|
-
|
|
Aug 10
2022
|
Martin S A Beck Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,469
-1.03%
|
$0
$0.65 P/Share
|
|
Aug 10
2022
|
Ramesh Balakrishnan Pres. & Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,169
-0.17%
|
$0
$0.65 P/Share
|
|
Aug 01
2022
|
Mariya Pylypiv Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,742
-0.05%
|
$0
$0.65 P/Share
|
|
Jul 11
2022
|
Martin S A Beck Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
215,000
+21.86%
|
-
|
|
Jul 11
2022
|
Ramesh Balakrishnan Pres. & Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
220,000
+1.44%
|
-
|
|
Jun 09
2022
|
Ramesh Balakrishnan Pres. & Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,414,947
-16.1%
|
$0
$0.66 P/Share
|
|
May 01
2022
|
Ramesh Balakrishnan Pres. & Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,795
-0.51%
|
$0
$0.76 P/Share
|
|
Mar 22
2022
|
Martin S A Beck Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
932,989
+33.39%
|
-
|
|
Mar 22
2022
|
Martin S A Beck Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
932,989
-43.29%
|
-
|
|
Jan 10
2022
|
Alfonso Gatmaitan Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,814
-4.19%
|
-
|
|
Jan 07
2022
|
Martin S A Beck Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
749,018
-25.79%
|
-
|
|
Dec 30
2021
|
Martin S A Beck Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
591,330
-16.92%
|
-
|
|
Dec 22
2021
|
Chirinjeev Kathuria Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+0.17%
|
-
|
|
Dec 22
2021
|
Avi S Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+33.62%
|
-
|
|
Dec 22
2021
|
Moshe Bar Siman Tov Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+34.03%
|
-
|
|
Dec 22
2021
|
Jerome Ringo Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+34.03%
|
-
|
|
Dec 22
2021
|
Agnes Rey Giraud |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+33.24%
|
-
|
|
Dec 22
2021
|
Neil Miotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,730
+29.79%
|
-
|